ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CNBX CNBX Pharmaceuticals Inc (QB)

0.00805
0.00005 (0.62%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 35,258
Bid Price 0.0068
Ask Price 0.018
News -
Day High 0.0086

Low
0.0061

52 Week Range

High
0.0487

Day Low 0.0072
Company Name Stock Ticker Symbol Market Type
CNBX Pharmaceuticals Inc (QB) CNBX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00005 0.62% 0.00805 16:01:11
Open Price Low Price High Price Close Price Prev Close
0.0079 0.0072 0.0086 0.00805 0.008
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12 35,258 $ 0.008465 $ 298 - 0.0061 - 0.0487
Last Trade Time Type Quantity Stock Price Currency
15:56:32 12,501 $ 0.00805 USD

CNBX Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
311.11k 17.03M 4.20M 410k -3.71M -0.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CNBX Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CNBX Message Board. Create One! See More Posts on CNBX Message Board See More Message Board Posts

Historical CNBX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00850.00940.00680.0086552115,956-0.00045-5.29%
1 Month0.01090.01150.0062250.0081626189,425-0.00285-26.15%
3 Months0.01120.0160.00610.0108099272,041-0.00315-28.13%
6 Months0.01290.018350.00610.0120673260,812-0.00485-37.60%
1 Year0.020.04870.00610.0188407371,248-0.01195-59.75%
3 Years0.18335.500.00610.0462198259,917-0.17525-95.61%
5 Years0.27115.500.00610.1540221267,985-0.26305-97.03%

CNBX Pharmaceuticals (QB) Description

CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.

Your Recent History

Delayed Upgrade Clock